IntegenX Raises $15.6M, Buys VC-backed GenVault

5 years ago

Genetic analysis company IntegenX has raised $15.6 million in venture capital, and acquired biotech company GenVault Corp. Life science investor Domain Associates led the round, which included participation from previous investors In-Q-Tel and RONAholdings LLC. GenVault’s existing investors QuestMark Partners, Cross Creek Partners, and Greenspring Associates now join the syndicate backing IntegenX. Pleasanton, Calif.-based IntegenX designs, manufactures and markets automated DNA and RNA based sample preparation.